NACL Industries delivered exceptional profitability improvements in the June 2026 quarter, with standalone net profit rising 64.8% to ₹23.57 crore compared to ₹14.30 crore in the corresponding quarter of the previous year. On a consolidated basis, net profit increased 60% to ₹20.84 crore from ₹13.04 crore in Q1 FY2026. The company's EBITDA improved to ₹39.72 crore from ₹33.14 crore year-on-year, with EBITDA margin expanding significantly to 10.36% from 7.47% in the previous year, demonstrating enhanced operational efficiency and cost management capabilities. As per multiple reports, this 229 basis points expansion in EBITDA margin successfully offset a 15.56% YoY contraction in consolidated revenue to ₹383.33 crore, showcasing the company's resilient operational health despite challenging market conditions.
The company demonstrated strong sequential recovery, returning to profitability after reporting a net loss of ₹0.86 crore in the March quarter. Revenue from operations rose 6.2% quarter-on-quarter to ₹383.33 crore from ₹360.95 crore in the preceding quarter, though it remained 14.5% lower year-on-year compared to ₹448.36 crore in the same quarter last fiscal year. Total expenses fell 17.6% year-on-year to ₹356.89 crore from ₹431.45 crore, aiding the recovery in profitability and demonstrating effective cost management during the quarter. The 15.56% drop in consolidated revenue to ₹383.33 crore from ₹450 crore in the same period last fiscal year underscores demand-side pressures in the domestic and global crop protection markets, with the company successfully extracting double-digit EBITDA margins from a smaller revenue pool through excellent cost management and operational efficiency.
Despite the revenue decline, operating profit margin (OPM) improved to 10.80% in the June 2026 quarter compared to 8.47% in the corresponding quarter of the previous year. The basic and diluted earnings per share (EPS) for the standalone entity were recorded at ₹1.01 for the quarter, up from ₹0.66 in the same period last year. According to the company's financial data, these margin improvements indicate better cost management and operational efficiency during the quarter, with the enhanced EBITDA performance reflecting improved operational efficiency across key business segments. The 229 basis points expansion in EBITDA margin to 10.36% showcases the company's resilient operational health and ability to maintain profitability despite challenging market conditions, with the divergence between declining top-line and rising bottom-line underscoring strong cost discipline and potential shift toward higher-margin formulations.
The Board of Directors approved the divestment of the company's entire equity stake in associate company Nasense Labs Private Limited for a total consideration of ₹8.15 crore. The stake will be sold to Mr. Kanumuru Satyanarayana Raju, with the transaction expected to be completed within the next three months subject to fulfillment of terms and conditions outlined in the Share Purchase Agreement. Post-completion, Nasense Labs Private Limited will cease to be an associate company of NACL Industries Limited. During the board meeting held on July 22, 2026, the company approved this strategic move to unlock capital and streamline the balance sheet. Additionally, the company allotted 65,000 equity shares during the quarter pursuant to the exercise of stock options and reported that funds raised through a rights issue in December 2025 have been utilized for intended purposes, with an unutilized amount of ₹2,445 lakhs deposited in an earmarked bank account.
NACL Industries shares were trading 3.56% lower at ₹204 on the National Stock Exchange following the quarterly results announcement. The stock had earlier gained over 2% following the strong Q1 FY27 earnings announcement, with the stock trading at ₹216.50 on NSE as of July 22, 2026, up by 2.35% from the previous closing price. However, the stock has since experienced some volatility, moving down by 0.84% to ₹209.76 as of July 22, 2026, 3:00 PM IST. The positive initial market response reflected investor confidence in the company's ability to deliver strong profit growth despite revenue challenges, with the 59.8% year-on-year increase in net profit to ₹20.84 crore and significant margin expansion demonstrating operational resilience. The company's market capitalization stands at ₹5,106.50 crore within the Pesticides/Agro Chemicals sector, with the stock showing a 52-week high of ₹302.95 and 52-week low of ₹112.62, indicating significant price volatility during the period.
